{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:19:19Z","timestamp":1760145559330,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The present study examined three hallucinogenic amphetamine derivatives, namely, 2,5-dimethoxy-4-iodoamphetamine (DOI) as well as 2,5-dimethoxy-4-methylamphetamine (DOM) and 4-methylmethcathinone (mephedrone). The objective of this study was to test the hypothesis that DOI, DOM, and mephedrone would increase the contractile force in isolated human atrial preparations in a manner similar to amphetamine. To this end, we measured contractile force under isometric conditions in electrically stimulated (1 Hz) human atrial preparations obtained during open surgery. DOI and DOM alone or in the presence of isoprenaline reduced the contractile force concentration-dependently in human atrial preparations. These negative inotropic effects of DOM and DOI were not attenuated by 10 \u00b5M atropine. However, mephedrone increased the contractile force in human atrial preparations in a concentration- and time-dependent manner. Furthermore, these effects were attenuated by the subsequent addition of 10 \u00b5M propranolol or pretreatment with 10 \u00b5M cocaine in the organ bath. Therefore, it can be concluded that amphetamine derivatives may exert opposing effects on cardiac contractile force. The precise mechanism by which DOI and DOM exert their negative inotropic effects remains unknown at present. The cardiac effects of mephedrone are probably due to the release of cardiac noradrenaline.<\/jats:p>","DOI":"10.3390\/ijms25168887","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T09:29:41Z","timestamp":1723714181000},"page":"8887","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opposite Contractile Effects of Amphetamine-Related Hallucinogenic Drugs in the Isolated Human Atrium"],"prefix":"10.3390","volume":"25","author":[{"given":"Joachim","family":"Neumann","sequence":"first","affiliation":[{"name":"Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britt","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Mid-German Heart Center, University Hospital Halle, 06097 Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-485X","authenticated-orcid":false,"given":"Ulrich","family":"Gergs","sequence":"additional","affiliation":[{"name":"Institute for Pharmacology and Toxicology, Medical Faculty, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/FJC.0000000000001536","article-title":"Contractile Effects of Amphetamine, Pseudoephedrine, Nor-pseudoephedrine (Cathine), and Cathinone on Atrial Preparations of Mice and Humans","volume":"83","author":"Neumann","year":"2024","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF00441948","article-title":"Hallucinogenic drug interactions at human brain 5-HT2 receptors: Implications for treating LSD-induced hallucinogenesis","volume":"98","author":"Sadzot","year":"1989","journal-title":"Psychopharmacology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","article-title":"Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: A comprehensive history, a re-evaluation of mechanisms, and its utility as a model","volume":"4","author":"Canal","year":"2012","journal-title":"Drug Test. Anal."},{"doi-asserted-by":"crossref","unstructured":"Ray, T.S. (2010). Psychedelics and the human receptorome. PLoS ONE, 5.","key":"ref_4","DOI":"10.1371\/annotation\/e580a864-cf13-40c2-9bd9-b9687a6f0fe4"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","article-title":"Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens","volume":"61","author":"Halberstadt","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.159.3822.1492.a","article-title":"2,5-Dimethoxy-4-methylamphetamine: New hallucinogenic drug","volume":"159","author":"Snyder","year":"1968","journal-title":"Science"},{"key":"ref_7","first-page":"924","article-title":"Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis","volume":"246","author":"Burris","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.2042-7158.1972.tb09081.x","article-title":"The pressor action of 2,5-dimethoxy-4-methylamphetamine in rats","volume":"24","author":"Huang","year":"1972","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0014-2999(75)90053-9","article-title":"Cardiovascular actions of 2,5-dimethoxy-4-methylamphetamine (DOM) in the cat","volume":"31","author":"Tadepalli","year":"1975","journal-title":"Eur. J. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drugalcdep.2017.04.024","article-title":"Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats","volume":"178","author":"Hicks","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/npp.2011.304","article-title":"The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue","volume":"37","author":"Baumann","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1124\/jpet.111.184119","article-title":"4-Methylmethcathinone (mephedrone): Neuropharmacological effects of a designer stimulant of abuse","volume":"339","author":"Hadlock","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2011.07.009","article-title":"Interaction of mephedrone with dopamine and serotonin targets in rats","volume":"22","author":"Escubedo","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_14","first-page":"1","article-title":"Lysergic acid diethylamide (LSD) has anti- \u03b2-adrenergic effects in the isolated human atrium: Abstract at the 9th German Pharm-Tox Summit 2024","volume":"397","author":"Jacob","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3109\/10641969409078025","article-title":"Systemic and regional haemodynamic effects of 1-(2,5-dimethoxy-4-iodo-phenyl)-2-aminopropane (DOI) and alpha-methyl-5-HT, in the anaesthetised rat","volume":"16","author":"Fournier","year":"1994","journal-title":"Clin. Exp. Hypertens."},{"key":"ref_16","first-page":"1027","article-title":"Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms","volume":"259","author":"Fisher","year":"1991","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(88)90698-X","article-title":"5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge","volume":"151","author":"McCall","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/00005344-199511000-00018","article-title":"Investigation of the mechanism by which ketanserin prolongs the duration of the cardiac action potential","volume":"26","author":"Talmant","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1067\/mhj.2000.110457","article-title":"Dofetilide: A new pure class III antiarrhythmic agent","volume":"140","author":"Falk","year":"2000","journal-title":"Am. Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10557-009-6163-x","article-title":"Dofetilide enhances the contractility of rat ventricular myocytes via augmentation of Na+-Ca2+ exchange","volume":"23","author":"Zhang","year":"2009","journal-title":"Cardiovasc. Drugs Ther."},{"doi-asserted-by":"crossref","unstructured":"Shad Kaneez, F. (2017). Production and function of serotonin in cardiac cells. SEROTONIN: A Chemical Messenger between All Types of Living Cells, IntechOpen.","key":"ref_21","DOI":"10.5772\/65233"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(90)90620-L","article-title":"Receptor mechanisms for 5-hydroxytryptamine (5-HT) in isolated ovine umbilical vein","volume":"184","author":"Zhang","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1002\/jcph.1918","article-title":"Pharmacology of Drugs Used as Stimulants","volume":"61","author":"Docherty","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00213-012-2855-1","article-title":"Comparison of the behavioral and cardiovascular effects of mephedrone with other drugs of abuse in rats","volume":"225","author":"Varner","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/dta.312","article-title":"The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone)","volume":"3","author":"Dargan","year":"2011","journal-title":"Drug Test. Anal."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/emj.2010.092288","article-title":"Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone","volume":"28","author":"Wood","year":"2011","journal-title":"Emerg. Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hup.2423","article-title":"Deaths of individuals aged 16-24 years in the UK after using mephedrone","volume":"30","author":"Loi","year":"2015","journal-title":"Hum. Psychopharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/emj.2010.103093","article-title":"Mephedrone toxicity in a Scottish emergency department","volume":"28","author":"Regan","year":"2011","journal-title":"Emerg. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/emj.2010.096636","article-title":"Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service","volume":"28","author":"James","year":"2011","journal-title":"Emerg. Med. J."},{"unstructured":"Brunton, L.L., and Knollmann, B.C. (2023). Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics, McGraw Hill Education. [14th ed.].","key":"ref_30"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1111\/bph.13547","article-title":"Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters","volume":"173","author":"Mayer","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"146740","DOI":"10.1016\/j.brainres.2020.146740","article-title":"Mephedrone and MDMA: A comparative review","volume":"1735","author":"Mead","year":"2020","journal-title":"Brain Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00210-022-02315-2","article-title":"Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations","volume":"396","author":"Neumann","year":"2023","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.toxlet.2023.06.012","article-title":"Methamphetamine increases force of contraction in isolated human atrial preparations through the release of noradrenaline","volume":"383","author":"Neumann","year":"2023","journal-title":"Toxicol. Lett."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/8887\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:37:06Z","timestamp":1760110626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/16\/8887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":34,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["ijms25168887"],"URL":"https:\/\/doi.org\/10.3390\/ijms25168887","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2024,8,15]]}}}